Циркуляция вариантов вируса гепатита в, несущих мутации в гене полимеразы, среди ВГВ-инфицированных и ВГВ/ВИЧ-коинфицированных пациентов
Tatyana V. Kozhanova, Л. Ю. Ильченко, Olga V. Isaeva et al. · Современные технологии в медицине · 2013
Cited by 0 works.
Authors
- Tatyana V. Kozhanova
- Л. Ю. Ильченко
- Olga V. Isaeva
- Сарыглар Анна Александровна
- Н. И. Миронова
- Н. И. Громова
- М. Н. Цыкина
- Ю. П. Зубков
- К. К. Кюрегян
- М. И. Михайлов
References
- Entecavir resistance is rare in nucleoside naïve patients with hepatitis B
- The clinical significance of surface antigen variants of hepatitis B virus
- Ultra‐Deep Pyrosequencing of Hepatitis B Virus Quasispecies from Nucleoside and Nucleotide Reverse‐Transcriptase Inhibitor (NRTI)–Treated Patients and NRTI‐Naive Patients
- Occult hepatitis B virus infection in chronic liver disease: Full-length genome and analysis of mutant surface promoter
- Combination of tenofovir and lamivudine versus tenofovir after lamivudine failure for therapy of hepatitis B in HIV-coinfection
- YSDD: a novel mutation in HBV DNA polymerase confers clinical resistance to lamivudine
- Character of HBV (hepatitis B virus) polymerase gene rtM204V/I and rtL180M mutation in patients with lamivudine resistance
- Review article: nucleoside analogues for the treatment of chronic hepatitis B
- Confronting chronic hepatitis B virus infection in HIV: new diagnostic tools and more weapons
- A novel pattern (sW195a) in surface gene of HBV DNA due to YSDD (L180M plus M204S) mutation selected during lamivudine therapy and successful treatment with adefovir dipivoxil